Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions"

被引:21
作者
Klose, J
Fechner, K
Beyermann, M
Krause, E
Wendt, N
Bienert, M
Rudolph, R
Rothemund, S
机构
[1] Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany
[2] Res Inst Mol Pharmacol, D-13125 Berlin, Germany
[3] Univ Halle Wittenberg, Inst Biotechnol, D-06120 Halle An Der Saale, Germany
关键词
D O I
10.1021/bi049022e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
large extracellular N-terminal domains (NTs) of class B G protein-coupled receptors serve as major ligand binding sites. However, little is known about the ligand requirements for interactions with these receptor domains. Recently, we have shown that the most potent CRF receptor agonist urocortin 1 (Ucn1) has two segregated receptor binding sites Ucn1(1-21) and Ucn1(32-40). For locating the receptor domains interacting with these two sites, we have investigated the binding of appropriate Ucn1 analogues to the receptor N-termini compared to the corresponding full-length receptors. For this purpose receptor NTs of CRF(rat) subtypes 1 and 2(a) without their signal sequences were overexpressed in Escherichia coli and folded in vitro. For CRF2(a)-rNT, which bears five cysteine residues (C2-C6), the disulfide arrangement C2-C5 and C4-C6 was found, leaving C3 free. This is consistent with the disulfide pattern of CRF1-rNT, which has six cysteines and in which C1 is paired with C3. Binding studies of N-terminally truncated or C-terminally modified Ucn1 analogues demonstrate that it is the C-terminal part, Ucn1(11-40), that binds to receptor NT, indicating a two-domain binding mechanism for Ucn binding to receptor NT. Since the binding of Ucn1 to the juxtamembrane domain has been shown to be segregated from binding to the receptor N-terminus [Hoare et al. (2004) Biochemistry 43, 3996-4011], a third binding domain should exist, probably comprising residues 8-10 of Ucn, which particularly contribute to a high-affinity binding to full-length receptors but not to receptor NT.
引用
收藏
页码:1614 / 1623
页数:10
相关论文
共 63 条
[1]  
AHMED AK, 1975, J BIOL CHEM, V250, P8477
[2]   N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction [J].
Assil, IQ ;
Abou-Samra, AB .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (05) :E1015-E1021
[3]   In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor [J].
Bazarsuren, A ;
Grauschopf, U ;
Wozny, M ;
Reusch, D ;
Hoffmann, E ;
Schaefer, W ;
Panzner, S ;
Rudolph, R .
BIOPHYSICAL CHEMISTRY, 2002, 96 (2-3) :305-318
[4]   Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking [J].
Behar, V ;
Bisello, A ;
Rosenblatt, M ;
Chorev, M .
ENDOCRINOLOGY, 1999, 140 (09) :4251-4261
[5]   A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor [J].
Beyermann, M ;
Fechner, K ;
Furkert, J ;
Krause, E ;
Bienert, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) :3324-3330
[6]   A role for a helical connector between two receptor binding sites of a long-chain peptide hormone [J].
Beyermann, M ;
Rothemund, S ;
Heinrich, N ;
Fechner, K ;
Furkert, J ;
Dathe, M ;
Winter, R ;
Krause, E ;
Bienert, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5702-5709
[7]   Role of glycosylation in expression and function of the human parathyroid hormone parathyroid hormone-related protein receptor [J].
Bisello, A ;
Greenberg, Z ;
Behar, V ;
Rosenblatt, M ;
Suva, LJ ;
Chorev, M .
BIOCHEMISTRY, 1996, 35 (49) :15890-15895
[8]   Differential responsiveness of CRF receptor subtypes to N-terminal truncation of peptidic ligands [J].
Brauns, O ;
Brauns, S ;
Zimmermann, B ;
Jahn, O ;
Spiess, J .
PEPTIDES, 2002, 23 (05) :881-888
[9]   Pharmacological and chemical properties of astressin, antisauvagine-30 and α-helCRF:: significance for behavioral experiments [J].
Brauns, O ;
Liepold, T ;
Radulovic, J ;
Spiess, J .
NEUROPHARMACOLOGY, 2001, 41 (04) :507-516
[10]   RENATURATION, PURIFICATION AND CHARACTERIZATION OF RECOMBINANT FAB-FRAGMENTS PRODUCED IN ESCHERICHIA-COLI [J].
BUCHNER, J ;
RUDOLPH, R .
BIO-TECHNOLOGY, 1991, 9 (02) :157-162